Arnljot Tveit

4.2k total citations
119 papers, 2.1k citations indexed

About

Arnljot Tveit is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Nutrition and Dietetics. According to data from OpenAlex, Arnljot Tveit has authored 119 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Cardiology and Cardiovascular Medicine, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Nutrition and Dietetics. Recurrent topics in Arnljot Tveit's work include Atrial Fibrillation Management and Outcomes (58 papers), Cardiac electrophysiology and arrhythmias (40 papers) and Cardiac Arrhythmias and Treatments (25 papers). Arnljot Tveit is often cited by papers focused on Atrial Fibrillation Management and Outcomes (58 papers), Cardiac electrophysiology and arrhythmias (40 papers) and Cardiac Arrhythmias and Treatments (25 papers). Arnljot Tveit collaborates with scholars based in Norway, Denmark and Sweden. Arnljot Tveit's co-authors include Harald Arnesen, Trygve Berge, Michael Abdelnoor, Ingebjørg Seljeflot, Steve Enger, Pål Smith, Marius Myrstad, Håkon Ihle‐Hansen, Peder L. Myhre and Helge Røsjø and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and CHEST Journal.

In The Last Decade

Arnljot Tveit

110 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnljot Tveit Norway 25 1.3k 303 255 233 178 119 2.1k
Paul N. Jensen United States 24 1.3k 1.0× 297 1.0× 107 0.4× 296 1.3× 540 3.0× 48 2.4k
Li Fan China 22 635 0.5× 231 0.8× 133 0.5× 222 1.0× 176 1.0× 120 2.0k
Vikram Agarwal United States 18 938 0.7× 349 1.2× 67 0.3× 236 1.0× 171 1.0× 39 1.7k
Chisa Matsumoto Japan 21 916 0.7× 202 0.7× 134 0.5× 176 0.8× 117 0.7× 123 1.6k
Jan Eritsland Norway 27 826 0.6× 415 1.4× 484 1.9× 216 0.9× 243 1.4× 81 2.0k
Saverio Iacopino Italy 24 3.1k 2.3× 394 1.3× 93 0.4× 235 1.0× 111 0.6× 158 3.6k
Tarek Kashour Saudi Arabia 22 522 0.4× 276 0.9× 135 0.5× 166 0.7× 204 1.1× 74 1.9k
D W T Nilsen Norway 24 483 0.4× 345 1.1× 382 1.5× 124 0.5× 266 1.5× 60 1.7k
Giuseppe Mulè Italy 30 1.6k 1.2× 351 1.2× 229 0.9× 290 1.2× 159 0.9× 140 2.8k
Stefan John Germany 25 813 0.6× 538 1.8× 142 0.6× 416 1.8× 206 1.2× 82 2.3k

Countries citing papers authored by Arnljot Tveit

Since Specialization
Citations

This map shows the geographic impact of Arnljot Tveit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnljot Tveit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnljot Tveit more than expected).

Fields of papers citing papers by Arnljot Tveit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnljot Tveit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnljot Tveit. The network helps show where Arnljot Tveit may publish in the future.

Co-authorship network of co-authors of Arnljot Tveit

This figure shows the co-authorship network connecting the top 25 collaborators of Arnljot Tveit. A scholar is included among the top collaborators of Arnljot Tveit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnljot Tveit. Arnljot Tveit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
4.
Ariansen, Inger, Marius Myrstad, Lars J. Kjerpeseth, et al.. (2025). Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study. EP Europace. 27(10). 1 indexed citations
5.
Nygård, Ståle, et al.. (2024). Sex differences in early-onset atrial fibrillation in Norwegian primary care: a retrospective national database analysis. Open Heart. 11(2). e002695–e002695. 1 indexed citations
6.
Hagberg, Guri, Marius Myrstad, Trygve Berge, et al.. (2024). Systolic blood pressure at age 40 and 30-year stroke risk in men and women. Open Heart. 11(2). e002805–e002805. 1 indexed citations
7.
Tveit, Arnljot, et al.. (2024). Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation. European Heart Journal - Cardiovascular Pharmacotherapy. 10(6). 515–525. 1 indexed citations
9.
Myhre, Peder L., Trygve Berge, Are A. Kalstad, et al.. (2023). Omega-3 fatty acid supplements and risk of atrial fibrillation and ‘micro-atrial fibrillation’: A secondary analysis from the OMEMI trial. Clinical Nutrition. 42(9). 1657–1660. 6 indexed citations
10.
Kalstad, Are A., Peder L. Myhre, Svein Solheim, et al.. (2023). von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction. Research and Practice in Thrombosis and Haemostasis. 7(4). 100164–100164.
11.
Ihle‐Hansen, Håkon, et al.. (2023). Impact of frailty on the performance of the National Early Warning Score 2 to predict poor outcome in patients hospitalised due to COVID-19. BMC Geriatrics. 23(1). 134–134. 1 indexed citations
13.
Janssens, Kristel, Jan Pål Loennechen, Guido Claessen, et al.. (2023). Effects of training adaption in endurance athletes with atrial fibrillation: protocol for a multicentre randomised controlled trial. BMJ Open Sport & Exercise Medicine. 9(2). e001541–e001541. 7 indexed citations
14.
Myhre, Peder L., Siri Lagethon Heck, Christian Prebensen, et al.. (2021). Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity. American Heart Journal. 242. 61–70. 23 indexed citations
15.
Kjerpeseth, Lars J., Jannicke Igland, Randi Selmer, et al.. (2020). Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014. Heart. 107(3). 201–207. 36 indexed citations
16.
Ihle‐Hansen, Håkon, Håkon Ihle‐Hansen, Trygve Berge, et al.. (2019). Carotid Atherosclerosis and Cognitive Function in a General Population Aged 63-65 Years: Data from the Akershus Cardiac Examination (ACE) 1950 Study. Journal of Alzheimer s Disease. 70(4). 1041–1049. 7 indexed citations
17.
Enger, Steve, et al.. (2016). Troponin I levels in permanent atrial fibrillation—impact of rate control and exercise testing. BMC Cardiovascular Disorders. 16(1). 79–79. 3 indexed citations
18.
Ariansen, Inger, et al.. (2011). Lung function and dyspnea in patients with permanent atrial fibrillation. European Journal of Internal Medicine. 22(5). 466–470. 9 indexed citations
19.
Tveit, Arnljot, Ingebjørg Seljeflot, Irene Grundvold, et al.. (2008). Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion. International Journal of Cardiology. 131(2). 234–239. 26 indexed citations
20.
Tveit, Arnljot, Ingebjørg Seljeflot, Irene Grundvold, et al.. (2007). Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Thrombosis Research. 121(4). 447–453. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026